VENLO, Netherlands, and SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Element Biosciences, Inc. today announced a strategic partnership to offer ...

Element’s inaugural virtual event on March 14, 2022, will provide more details on the Loop Genomics technology and its integration with the Element platform.

Element still has a long way to go in its bid to rival Illumina, a genomics giant that dominates 80% of the sequencing market and has more than 23,000 instruments in use around the world. That ...

With its DNA sequencing platform Aviti, San Diego-based startup Element Biosciences is among the many players in this R&D sandbox. Today, the company announced that it has raised a $277 million ...

Phase Genomics and Element will share additional details and an application note at the upcoming AACR conference, April 14-19 (Phase Genomics booth #561, Element Biosciences booth #559).

SAN DIEGO, June 26, 2024 /PRNewswire/ -- Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced the additions of two industry-leading artificial ...

As of September 30, 2023, QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at https://www.qiagen.com. About Element Biosciences, Inc.